-+ 0.00%
-+ 0.00%
-+ 0.00%

CPC SCIENTIFIC ANNOUNCES U.S. FDA PRE-LICENSE INSPECTION (PLI) SUCCESSFULLY COMPLETED AT ITS HANGZHOU CGMP MANUFACTURING FACILITY FOR HEPCLUDEX® API, ESTABLISHING A PROVEN TRACK RECORD UNDER THE STRINGENT BLA PATHWAY

Reuters·08/05/2026 12:11:00

Please log in to view news